GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Edwards Lifesciences Corp (XTER:EWL) » Definitions » Ending Cash Position

Edwards Lifesciences (XTER:EWL) Ending Cash Position : €2,913 Mil (As of Mar. 2025)


View and export this data going back to 1990. Start your Free Trial

What is Edwards Lifesciences Ending Cash Position?

Edwards Lifesciences's Ending Cash Position for the quarter that ended in Mar. 2025 was €2,913 Mil.

Edwards Lifesciences's quarterly Ending Cash Position declined from Sep. 2024 (€3,319 Mil) to Dec. 2024 (€2,921 Mil) and declined from Dec. 2024 (€2,921 Mil) to Mar. 2025 (€2,913 Mil).

Edwards Lifesciences's annual Ending Cash Position increased from Dec. 2022 (€729 Mil) to Dec. 2023 (€1,053 Mil) and increased from Dec. 2023 (€1,053 Mil) to Dec. 2024 (€2,921 Mil).

Edwards Lifesciences Ending Cash Position Historical Data

The historical data trend for Edwards Lifesciences's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Edwards Lifesciences Ending Cash Position Chart

Edwards Lifesciences Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 986.56 767.65 729.33 1,052.72 2,921.15

Edwards Lifesciences Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,130.68 1,540.38 3,318.74 2,921.15 2,912.64

Edwards Lifesciences Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Edwards Lifesciences's Ending Cash Position for the fiscal year that ended in Dec. 2024 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=1096.339+1824.815
=2,921

Edwards Lifesciences's Ending Cash Position for the quarter that ended in Mar. 2025 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=2829.39+83.25
=2,913

Edwards Lifesciences Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Edwards Lifesciences's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Edwards Lifesciences Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Edwards Lifesciences Corp (XTER:EWL) » Definitions » Ending Cash Position
Comparable Companies
DXCM STE ZBH PODD PEN GMED MASI BIO BRKR GKOS ABT BSX SYK MDT XTER:SHL SZSE:300760 XAMS:PHIA XSWX:SOON SHSE:688271 TSE:7733
Traded in Other Exchanges
EW:USA EW:Mexico 1EW:Italy EWL:Germany EWL:Germany E1WL34:Brazil EWLS:Austria
Address
One Edwards Way, Irvine, CA, USA, 92614
Website
https://www.edwards.com
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.